A European Medicines Agency (EMA) group has recommended actions the regulator and industry can take to accelerate regulatory ...
The European Medicines Agency has finalized its reflection paper on a tailored clinical approach to biosimilar development, ...
Access to life-saving medicines often depends not only on scientific breakthroughs, but on how quickly and efficiently regulatory systems can evaluate and approve them.
Financial conflicts of interest amongst abstracts, speakers, and planning committee members at the American Society of Clinical Oncology Annual Meeting No significant financial relationships to ...
Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency has recommended the approval of Dupixent in the European Union for adults with ...
US, European regulators set principles for 'good AI practice' in drug development The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and ...
Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible use of artificial intelligence in developing medicines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results